Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41


Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol.

Chimento A, De Amicis F, Sirianni R, Sinicropi MS, Puoci F, Casaburi I, Saturnino C, Pezzi V.

Int J Mol Sci. 2019 Mar 19;20(6). pii: E1381. doi: 10.3390/ijms20061381. Review.


Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer.

De Amicis F, Chimento A, Montalto FI, Casaburi I, Sirianni R, Pezzi V.

Int J Mol Sci. 2019 Mar 3;20(5). pii: E1087. doi: 10.3390/ijms20051087. Review.


Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment.

Chimento A, Casaburi I, Avena P, Trotta F, De Luca A, Rago V, Pezzi V, Sirianni R.

Front Endocrinol (Lausanne). 2019 Jan 21;9:807. doi: 10.3389/fendo.2018.00807. eCollection 2018. Review.


Identifying genes with tri-modal association with survival and tumor grade in cancer patients.

Zhang M, Wang T, Sirianni R, Shaul PW, Xie Y.

BMC Bioinformatics. 2019 Jan 8;20(1):13. doi: 10.1186/s12859-018-2582-7.


Catalytic Double Cyclization Process for Antitumor Agents against Breast Cancer Cell Lines.

Mancuso R, Ziccarelli I, Chimento A, Marino N, Della Ca' N, Sirianni R, Pezzi V, Gabriele B.

iScience. 2018 May 25;3:279-288. doi: 10.1016/j.isci.2018.04.022. Epub 2018 May 3.


Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment.

Casaburi I, Chimento A, De Luca A, Nocito M, Sculco S, Avena P, Trotta F, Rago V, Sirianni R, Pezzi V.

Front Endocrinol (Lausanne). 2018 Sep 11;9:525. doi: 10.3389/fendo.2018.00525. eCollection 2018. Review.


GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway.

Casaburi I, Avena P, De Luca A, Sirianni R, Rago V, Chimento A, Trotta F, Campana C, Rainey WE, Pezzi V.

Oncotarget. 2017 Dec 14;8(70):115609-115619. doi: 10.18632/oncotarget.23314. eCollection 2017 Dec 29.


Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth.

De Luca A, Avena P, Sirianni R, Chimento A, Fallo F, Pilon C, Casaburi I, Pezzi V.

Cells. 2017 Nov 7;6(4). pii: E42. doi: 10.3390/cells6040042.


Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment.

Chimento A, Sirianni R, Saturnino C, Caruso A, Sinicropi MS, Pezzi V.

Mini Rev Med Chem. 2016;16(9):699-709. Review.


Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC).

Casaburi I, Avena P, De Luca A, Chimento A, Sirianni R, Malivindi R, Rago V, Fiorillo M, Domanico F, Campana C, Cappello AR, Sotgia F, Lisanti MP, Pezzi V.

Oncotarget. 2015 Sep 22;6(28):25135-48. doi: 10.18632/oncotarget.4722.


Human sperm liver receptor homolog-1 (LRH-1) acts as a downstream target of the estrogen signaling pathway.

Montanaro D, Santoro M, Carpino A, Perrotta I, De Amicis F, Sirianni R, Rago V, Gervasi S, Aquila S.

J Anat. 2015 Oct;227(4):541-9. doi: 10.1111/joa.12352. Epub 2015 Aug 4.


GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.

Chimento A, Sirianni R, Casaburi I, Zolea F, Rizza P, Avena P, Malivindi R, De Luca A, Campana C, Martire E, Domanico F, Fallo F, Carpinelli G, Cerquetti L, Amendola D, Stigliano A, Pezzi V.

Oncotarget. 2015 Aug 7;6(22):19190-203.


GPER Signaling in Spermatogenesis and Testicular Tumors.

Chimento A, Sirianni R, Casaburi I, Pezzi V.

Front Endocrinol (Lausanne). 2014 Mar 6;5:30. doi: 10.3389/fendo.2014.00030. eCollection 2014. Review.


Role of estrogen receptors and g protein-coupled estrogen receptor in regulation of hypothalamus-pituitary-testis axis and spermatogenesis.

Chimento A, Sirianni R, Casaburi I, Pezzi V.

Front Endocrinol (Lausanne). 2014 Jan 16;5:1. doi: 10.3389/fendo.2014.00001. eCollection 2014. Review.


1α,25-Dihydroxyvitamin D₃ inhibits the human H295R cell proliferation by cell cycle arrest: a model for a protective role of vitamin D receptor against adrenocortical cancer.

Pilon C, Urbanet R, Williams TA, Maekawa T, Vettore S, Sirianni R, Pezzi V, Mulatero P, Fassina A, Sasano H, Fallo F.

J Steroid Biochem Mol Biol. 2014 Mar;140:26-33. doi: 10.1016/j.jsbmb.2013.11.008. Epub 2013 Nov 20.


27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.

Wu Q, Ishikawa T, Sirianni R, Tang H, McDonald JG, Yuhanna IS, Thompson B, Girard L, Mineo C, Brekken RA, Umetani M, Euhus DM, Xie Y, Shaul PW.

Cell Rep. 2013 Nov 14;5(3):637-45. doi: 10.1016/j.celrep.2013.10.006. Epub 2013 Nov 7.


Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines.

Chimento A, Sala M, Gomez-Monterrey IM, Musella S, Bertamino A, Caruso A, Sinicropi MS, Sirianni R, Puoci F, Parisi OI, Campana C, Martire E, Novellino E, Saturnino C, Campiglia P, Pezzi V.

Bioorg Med Chem Lett. 2013 Dec 1;23(23):6401-5. doi: 10.1016/j.bmcl.2013.09.054. Epub 2013 Sep 25.


Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells.

Chimento A, Casaburi I, Rosano C, Avena P, De Luca A, Campana C, Martire E, Santolla MF, Maggiolini M, Pezzi V, Sirianni R.

Mol Nutr Food Res. 2014 Mar;58(3):478-89. doi: 10.1002/mnfr.201300323. Epub 2013 Sep 9.


Synthesis of a new bis(indolyl)methane that inhibits growth and induces apoptosis in human prostate cancer cells.

Marrelli M, Cachet X, Conforti F, Sirianni R, Chimento A, Pezzi V, Michel S, Statti GA, Menichini F.

Nat Prod Res. 2013;27(21):2039-45. doi: 10.1080/14786419.2013.824440. Epub 2013 Aug 20.


Synthesis and cytotoxic activity evaluation of 2,3-thiazolidin-4-one derivatives on human breast cancer cell lines.

Sala M, Chimento A, Saturnino C, Gomez-Monterrey IM, Musella S, Bertamino A, Milite C, Sinicropi MS, Caruso A, Sirianni R, Tortorella P, Novellino E, Campiglia P, Pezzi V.

Bioorg Med Chem Lett. 2013 Sep 1;23(17):4990-5. doi: 10.1016/j.bmcl.2013.06.051. Epub 2013 Jun 26.


Supplemental Content

Loading ...
Support Center